Delivery of Anticancer Drugs Using Microbubble-Assisted Ultrasound in a 3D Spheroid Model - Nutrition, croissance et cancer (U 1069)
Journal Articles Molecular Pharmaceutics Year : 2024

Delivery of Anticancer Drugs Using Microbubble-Assisted Ultrasound in a 3D Spheroid Model

Corentin Alix
Ayache Bouakaz
Sophie Serrière

Abstract

Tumor spheroids are promising three-dimensional (3D) in vitro tumor models for the evaluation of drug delivery methods. The design of noninvasive and targeted drug methods is required to improve the intratumoral bioavailability of chemotherapeutic drugs and reduce their adverse off-target effects. Among such methods, microbubble-assisted ultrasound (MB-assisted US) is an innovative modality for noninvasive targeted drug delivery. The aim of the present study is to evaluate the efficacy of this US modality for the delivery of bleomycin, doxorubicin, and irinotecan in colorectal cancer (CRC) spheroids. MB-assisted US permeabilized the CRC spheroids to propidium iodide, which was used as a drug model without affecting their growth and viability. Histological analysis and electron microscopy revealed that MB-assisted US affected only the peripheral layer of the CRC spheroids. The acoustically mediated bleomycin delivery induced a significant decrease in CRC spheroid growth in comparison to spheroids treated with bleomycin alone. However, this US modality did not improve the therapeutic efficacy of doxorubicin and irinotecan on CRC spheroids. In conclusion, this study demonstrates that tumor spheroids are a relevant approach to evaluate the efficacy of MB-assisted US for the delivery of chemotherapeutics.
Fichier principal
Vignette du fichier
Accepted version_HAL.pdf (1.42 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

inserm-04374054 , version 1 (05-01-2024)

Identifiers

Cite

Marie Roy, Corentin Alix, Julien Burlaud-Gaillard, Damien Fouan, William Raoul, et al.. Delivery of Anticancer Drugs Using Microbubble-Assisted Ultrasound in a 3D Spheroid Model. Molecular Pharmaceutics, 2024, Online ahead of print. ⟨10.1021/acs.molpharmaceut.3c00921⟩. ⟨inserm-04374054⟩
353 View
45 Download

Altmetric

Share

More